Article: Health Status of Children & Young People With CAH In The UK
A recently published reseach paper “Health Status of Children and Young Persons with Congenital Adrenal Hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study” in the in European Journal of Endocrinology concludes that ‘(there is) an increased prevalence of problems with growth and weight gain in CAH children and (a suggestion of) reduced quality of life’. (The research) ‘highlights the urgent need to optimise management and monitoring strategies to improve long-term health outcomes.’.
Read the full research paper here:
https://eje.bioscientifica.com/view/journals/eje/aop/eje-21-1109/eje-21-1109.xml
Recent Blog Posts
What you should know about COVID-19 – updated 10th August 2021
Guidance from other organizations is continually being issued and we'll do our best to link to them below - please keep checking back here for more updates. UPDATE 10th August 2021 Article: “ChAdOx1 SARS‐CoV‐2 vaccination: A putative precipitant of adrenal crises”...
New NICE Guidelines – identification and management of adrenal insufficiency
The publication of new NICE (National Institute for Health and Care Excellence) guidelines - "Adrenal insufficiency: identification and management" marks a significant advancement in the management and treatment of primary, secondary and tertiary adrenal...
Survey: Paediatric Adrenal Insufficiency Education
This project, led by Edge Hill University is working with NHS clinicians to develop national education standards and resources for sick day/emergency management of adrenal insufficiency in children and young people. The project would like to hear the views of parents...
Treatment Research Update – Crinetics Atumelnant (CRN04894)
Atumelnant (CRN04894) is in development by Crinetics for the treatment of congenital adrenal hyperplasia (CAH) and ACTH-dependent Cushing's syndrome. It is an oral, selective ACTH antagonist. Atumelnant is now in Phase 2 of development and you can read the latest...